BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, December 16, 2025
See today's BioWorld
Home
» Conflict between India state and national regulator hits pharmas
To read the full story,
subscribe
or
sign in
.
Conflict between India state and national regulator hits pharmas
June 8, 2017
By
T.V. Padma
NEW DELHI – India's national drug regulator has stopped individual state drug regulators from independently issuing manufacturing licenses to companies that have not acquired prior manufacturing approval from the Drug Controller General of India.
BioWorld